Lazar A Bojic

Lazar A Bojic

UNVERIFIED PROFILE

Are you Lazar A Bojic?   Register this Author

Register author
Lazar A Bojic

Lazar A Bojic

Publications by authors named "Lazar A Bojic"

Are you Lazar A Bojic?   Register this Author

6Publications

68Reads

6Profile Views

Quantitative profiling of oxylipins in plasma and atherosclerotic plaques of hypercholesterolemic rabbits.

Anal Bioanal Chem 2016 Jan 28;408(1):97-105. Epub 2015 Oct 28.

Merck and Co., Inc, Merck Research Laboratories, Kenilworth, NJ, 07033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00216-015-9105-4DOI Listing
January 2016

Lipidome of atherosclerotic plaques from hypercholesterolemic rabbits.

Int J Mol Sci 2014 Dec 15;15(12):23283-93. Epub 2014 Dec 15.

Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms151223283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284766PMC
December 2014

PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity.

J Lipid Res 2014 07 26;55(7):1254-66. Epub 2014 May 26.

Vascular Biology, Robarts Research Institute, The University of Western Ontario, London, Ontario, Canada, N6A 5B7 Departments of Biochemistry, The University of Western Ontario, London, Ontario, Canada, N6A 5B7 Medicine, The University of Western Ontario, London, Ontario, Canada, N6A 5B7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.M046037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076091PMC
July 2014

Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.

Arterioscler Thromb Vasc Biol 2014 Jan 24;34(1):52-60. Epub 2013 Oct 24.

From the Department of Vascular Biology, Robarts Research Institute (L.A.B., A.C.B., S.S.C., D.E.T., B.G.S., J.Y.E., C.G.S., H.Y., J.G.P., M.W.H.), London, Ontario, Canada; and Departments of Biochemistry (L.A.B., A.C.B., S.S.C., J.G.P., M.W.H.), Medicine (D.E.T., J.Y.E., C.G.S., R.G.T., J.G.P., M.W.H.), and Physiology and Pharmacology (R.G.T.), The University of Western Ontario, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.113.301830DOI Listing
January 2014

Peroxisome proliferator-activated receptor δ: a multifaceted metabolic player.

Curr Opin Lipidol 2013 Apr;24(2):171-7

Department of Biochemistry, Robarts Research Institute, The University of Western Ontario, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0b013e32835cc949DOI Listing
April 2013

Activation of peroxisome proliferator-activated receptor δ inhibits human macrophage foam cell formation and the inflammatory response induced by very low-density lipoprotein.

Arterioscler Thromb Vasc Biol 2012 Dec 27;32(12):2919-28. Epub 2012 Sep 27.

Vascular Biology, Robarts Research Institute, Department of Biochemistry, The University of Western Ontario, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.112.255208DOI Listing
December 2012